Qube Research & Technologies (QRT)
PPH icon

Qube Research & Technologies (QRT)’s VanEck Pharmaceutical ETF PPH Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.09M Buy
46,536
+18,291
+65% +$1.89M ﹤0.01% 1619
2026
Q1 		$2.93M Buy
+28,245
New +$3.01M ﹤0.01% 1947
2025
Q4 		– Sell
-75,844
Closed -$6.85M – 3994
2025
Q3 		$6.85M Buy
75,844
+59,654
+368% +$5.23M 0.01% 1545
2025
Q2 		$1.42M Buy
16,190
+16,074
+13,857% +$1.39M ﹤0.01% 2332
2025
Q1 		$10.6K Sell
116
-22,736
-99% -$2.05M ﹤0.01% 3273
2024
Q4 		$1.97M Sell
22,852
-27,634
-55% -$2.5M ﹤0.01% 1885
2024
Q3 		$4.8M Buy
50,486
+26,590
+111% +$2.53M 0.01% 1409
2024
Q2 		$2.19M Sell
23,896
-21,180
-47% -$1.89M ﹤0.01% 1578
2024
Q1 		$4.09M Buy
45,076
+29,433
+188% +$2.58M 0.01% 1355
2023
Q4 		$1.27M Sell
15,643
-2,859
-15% -$224K ﹤0.01% 1785
2023
Q3 		$1.48M Buy
18,502
+10,888
+143% +$878K ﹤0.01% 1544
2023
Q2 		$600K Buy
7,614
+2,345
+45% +$184K ﹤0.01% 1471
2023
Q1 		$409K Buy
+5,269
New +$406K ﹤0.01% 1630
2022
Q4 		– Sell
-5,327
Closed -$358K – 2881
2022
Q3 		$358K Buy
5,327
+2,416
+83% +$178K ﹤0.01% 1574
2022
Q2 		$224K Buy
2,911
+2,273
+356% +$177K ﹤0.01% 1687
2022
Q1 		$51K Buy
638
+230
+56% +$17.6K ﹤0.01% 2183
2021
Q4 		$31K Buy
+408
New +$30.3K ﹤0.01% 2325
2021
Q3 		– Sell
-3,280
Closed -$240K – 2661
2021
Q2 		$240K Buy
+3,280
New +$234K ﹤0.01% 1708

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Qube Research & Technologies (QRT)'s PPH Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its VanEck Pharmaceutical ETF (PPH) stake by 65% in Q2 2026, buying an estimated $1.89M and bringing the position to 46,536 shares worth $5.09M. The position accounts for ﹤0.01% of the portfolio, ranked #1619.

Qube Research & Technologies (QRT) first reported a position in PPH in Q2 2021 and has held it in 18 quarters since. The position peaked at $6.85M in Q3 2025. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • Qube Research & Technologies (QRT) held 46,536 shares of VanEck Pharmaceutical ETF worth $5.09M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 18,291 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $1.89M.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1619 holding.
  • Qube Research & Technologies (QRT) first reported a position in VanEck Pharmaceutical ETF in Q2 2021 and has held it in 18 quarters since.
  • Qube Research & Technologies (QRT)'s VanEck Pharmaceutical ETF position peaked at $6.85M in Q3 2025.
  • 148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.